BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 7521916)

  • 1. Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication.
    Li X; Mak J; Arts EJ; Gu Z; Kleiman L; Wainberg MA; Parniak MA
    J Virol; 1994 Oct; 68(10):6198-206. PubMed ID: 7521916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site.
    Wakefield JK; Rhim H; Morrow CD
    J Virol; 1994 Mar; 68(3):1605-14. PubMed ID: 7508999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys).
    Das AT; Klaver B; Berkhout B
    J Virol; 1995 May; 69(5):3090-7. PubMed ID: 7707537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys).
    Wakefield JK; Wolf AG; Morrow CD
    J Virol; 1995 Oct; 69(10):6021-9. PubMed ID: 7545240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of the human immunodeficiency virus type 1 Pol protein and the primer binding site in the placement of primer tRNA(3Lys) onto viral genomic RNA.
    Liang C; Rong L; Morin N; Cherry E; Huang Y; Kleiman L; Wainberg MA
    J Virol; 1997 Dec; 71(12):9075-86. PubMed ID: 9371564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletions in the tRNA(Lys) primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription.
    Rhim H; Park J; Morrow CD
    J Virol; 1991 Sep; 65(9):4555-64. PubMed ID: 1714513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His).
    Wakefield JK; Kang SM; Morrow CD
    J Virol; 1996 Feb; 70(2):966-75. PubMed ID: 8551637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in both the U5 region and the primer-binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription.
    Kang SM; Wakefield JK; Morrow CD
    Virology; 1996 Aug; 222(2):401-14. PubMed ID: 8806524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic evidence of the interaction between tRNA(Lys,3) and U5 facilitating efficient initiation of reverse transcription by human immunodeficiency virus type 1.
    Zhang Z; Kang SM; Morrow CD
    AIDS Res Hum Retroviruses; 1998 Jul; 14(11):979-88. PubMed ID: 9686644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles.
    Mak J; Jiang M; Wainberg MA; Hammarskjöld ML; Rekosh D; Kleiman L
    J Virol; 1994 Apr; 68(4):2065-72. PubMed ID: 7511167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the interaction between tRNA and primer binding site from characterization of a unique HIV-1 virus which stably maintains dual PBS complementary to tRNA(Gly) and tRNA(His).
    Li Y; Zhang Z; Kang SM; Buescher JL; Morrow CD
    Virology; 1997 Nov; 238(2):273-82. PubMed ID: 9400600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for an human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA(His).
    Zhang Z; Kang SM; LeBlanc A; Hajduk SL; Morrow CD
    Virology; 1996 Dec; 226(2):306-17. PubMed ID: 8955050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of deoxyoligonucleotide and tRNA(Lys-3) as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction.
    Arts EJ; Li X; Gu Z; Kleiman L; Parniak MA; Wainberg MA
    J Biol Chem; 1994 May; 269(20):14672-80. PubMed ID: 7514178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNA(Met).
    Kang SM; Zhang Z; Morrow CD
    J Virol; 1997 Jan; 71(1):207-17. PubMed ID: 8985340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast tRNA(Phe) expressed in human cells can be selected by HIV-1 for use as a reverse transcription primer.
    Kelly NJ; Morrow CD
    Virology; 2003 Sep; 313(2):354-63. PubMed ID: 12954204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective replication in human immunodeficiency virus type 1 when non-primers are used for reverse transcription.
    Wei M; Cen S; Niu M; Guo F; Kleiman L
    J Virol; 2005 Jul; 79(14):9081-7. PubMed ID: 15994802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site.
    Li X; Quan Y; Arts EJ; Li Z; Preston BD; de Rocquigny H; Roques BP; Darlix JL; Kleiman L; Parniak MA; Wainberg MA
    J Virol; 1996 Aug; 70(8):4996-5004. PubMed ID: 8764006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The G490E mutation in reverse transcriptase does not impact tRNA primer selection by HIV-1 with altered PBS and A-loop.
    Xu W; Morrow CD
    Virology; 2006 Sep; 352(2):380-9. PubMed ID: 16781756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.
    Han W; Wind-Rotolo M; Kirkman RL; Morrow CD
    Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A structured RNA motif is involved in correct placement of the tRNA(3)(Lys) primer onto the human immunodeficiency virus genome.
    Beerens N; Klaver B; Berkhout B
    J Virol; 2000 Mar; 74(5):2227-38. PubMed ID: 10666253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.